Subcutaneous Opdivo showed comparable effectiveness, safety and tolerability to IV Opdivo in advanced clear cell renal cell ...

The quest for more effective cancer radiotherapy continues apace, with Telix Pharmaceuticals (ASX:TLX) today reporting “encouraging” preliminary results from its phase II study to treat recurrent high ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 7.23%, which has investors questioning if this is right time to ...

A bill requiring Iowa students to pass the same test given to those who apply for U.S. citizenship is headed to Gov. Kim ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

A federal judge scolded the Trump administration on Tuesday for dragging its feet in complying with a Supreme Court order ...

AI software piloted the Maserati MC20 supercar, with "a driving robot" powering steering wheel movements at NASA's Launch and ...

Xencor's stock drops 65%, hitting all-time lows. Focus shifts to autoimmune research, but no near-term catalysts. Read why ...

The OnePlus 13R deviates a bit from the standard path paved by its predecessors and ticks more boxes for a reasonable price ...

Delay in MMJ Biopharma Cultivation’s Application Sparks Calls for DEA Accountability and Reform "This isn't just a case of bureaucratic red tape or administrative lag-this appears to be a deliberate ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

Call it what you will — a gut instinct, a sixth sense, or even a "spidey sense" — but at some point, everyone has had a ...